Elizabeth A Raetz Selected Research

Bortezomib (Velcade)

3/2024	MRD at the End of Induction and EFS in T-cell Lymphoblastic Lymphoma: Children's Oncology Group Trial AALL1231.
1/2022	Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
1/2019	Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth A Raetz Research Topics

Disease

61	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2024 - 04/2005
14	Leukemia 04/2024 - 10/2002
13	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023 - 08/2006
12	Neoplasms (Cancer) 01/2022 - 04/2005
9	Residual Neoplasm 07/2023 - 06/2011
7	Hypersensitivity (Allergy) 12/2023 - 10/2010
6	Philadelphia Chromosome 07/2023 - 09/2014
5	Infections 07/2023 - 08/2008
4	Genetic Predisposition to Disease (Genetic Predisposition) 03/2024 - 01/2016
4	Lymphoma (Lymphomas) 11/2023 - 08/2014
4	Pancreatitis 01/2023 - 10/2010
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2007
3	Osteonecrosis (Kienbock's Disease) 12/2023 - 10/2015
2	Sepsis (Septicemia) 01/2023 - 01/2021
2	Hyperbilirubinemia 12/2022 - 01/2022
2	Cytopenia 01/2022 - 01/2018
2	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 07/2015
1	Heart Arrest (Cardiac Arrest) 07/2023
1	Tics (Tic) 01/2023
1	Hyperammonemia 01/2023
1	Genetic Risk Score 12/2022
1	Bacteremia 10/2021
1	Neutropenia 10/2021
1	Febrile Neutropenia 01/2021
1	Down Syndrome (Down's Syndrome) 01/2021
1	Disease Progression 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Mucositis 01/2021
1	Central Nervous System Diseases (CNS Diseases) 10/2020
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2019
1	Glucosephosphate Dehydrogenase Deficiency 01/2019
1	Multiple Myeloma 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2018

Drug/Important Bio-Agent (IBA)

12	Asparaginase (Elspar)FDA Link 12/2023 - 10/2010
9	pegaspargase (Oncaspar)FDA Link 10/2021 - 07/2015
8	Methotrexate (Mexate)FDA LinkGeneric 12/2022 - 07/2015
6	Proteins (Proteins, Gene)FDA Link 03/2024 - 09/2002
3	Bortezomib (Velcade)FDA Link 03/2024 - 01/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 08/2017
3	Inotuzumab OzogamicinIBA 01/2022 - 01/2019
3	ChromatinIBA 06/2021 - 07/2014
3	nelarabine (506U78)FDA Link 10/2020 - 07/2015
3	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 05/2006
3	Phosphotransferases (Kinase)IBA 12/2019 - 09/2014
3	RNA (Ribonucleic Acid)IBA 07/2015 - 03/2013
2	Cyclin DIBA 11/2023 - 01/2022
2	palbociclibIBA 11/2023 - 01/2022
2	Dasatinib (BMS 354825)FDA Link 07/2023 - 01/2018
2	Imatinib Mesylate (Gleevec)FDA Link 07/2023 - 01/2018
2	Transaminases (Aminotransferases)IBA 01/2023 - 12/2022
2	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 01/2021
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 12/2022 - 01/2019
2	lestaurtinibIBA 05/2021 - 01/2021
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 08/2014
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 10/2016
2	Leucovorin (Folinic Acid)FDA Link 10/2020 - 10/2018
2	Cytokine Receptors (Cytokine Receptor)IBA 12/2019 - 01/2017
2	AntibodiesIBA 01/2018 - 08/2014
2	Monoclonal AntibodiesIBA 01/2018 - 08/2008
2	epratuzumabIBA 07/2015 - 08/2008
2	ProteomeIBA 01/2007 - 05/2006
1	Anesthetics (Anesthetic Agents)IBA 04/2024
1	MethyltransferasesIBA 05/2023
1	Lysine (L-Lysine)FDA Link 05/2023
1	insulin receptor-related receptor (IRR)IBA 01/2023
1	recombinant-rywn asparaginase erwinia chrysanthemiIBA 01/2023
1	Alanine Transaminase (SGPT)IBA 12/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2022
1	Proteasome InhibitorsIBA 01/2022
1	ribociclibIBA 01/2022
1	Cyclin D3IBA 01/2022
1	Drug CombinationsIBA 01/2022
1	Cytotoxins (Cytolysins)IBA 01/2022
1	Antigen Receptors (Antigen Receptor)IBA 04/2021
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2021
1	blinatumomabIBA 01/2021
1	AntigensIBA 01/2021
1	ElementsIBA 12/2019
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2019
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	AnthracyclinesIBA 01/2019
1	Essential Amino AcidsIBA 01/2019
1	AsparagineIBA 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019
1	methylervineIBA 10/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018
1	daratumumabIBA 01/2018
1	Clofarabine (Clolar)FDA Link 01/2018

Therapy/Procedure

41	Therapeutics 04/2024 - 04/2005
27	Drug Therapy (Chemotherapy) 11/2023 - 08/2008
4	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2019
2	Cranial Irradiation 10/2018 - 01/2018
1	Induction Chemotherapy 11/2023
1	Transplantation 07/2023
1	Stem Cell Transplantation 07/2023
1	Catheters 01/2023
1	Treatment Delay 10/2021
1	Immunotherapy 01/2018